Patience is difficult. You have come this far.Caution: The comments below are mine alone. Follow your gut and mind. Based on the last posts, all I want to say is "Don't follow a fool with a shiny new object just because they tell you to and promise you sunshine and daisies in their high risk play"
By the way, Anyone who gives you advice to sell what YOU have nurturedand move over to their pumped up play (AND THEY HAVE 270 Ignores) shouldprobably be ignored by you also.... Don't ya think.
-----------
Anyone who was here to watch Phase 2B implode and is considering selling NOW is out of their mind.
You have been through the pain of watching it all collapse around you.
You dusted yourself off.
Maybe you even bought some more.
I know I did.
Now here we are with an ICON on the board who is a legend in the field.
We have a new Exec. Chairman to drive the bus and they know business and science.
We still have brilliant minds working on the research. We may eventually have a Nobel laureate among them one day.
We had a successful but confusing Phase 2b trial but the FDA understands the validity of the findings.
We are awaiting a word (of some sort) from the Dept of Defense.
We have TBI research going (yes, it is slow but will accelerate now).
We have MS research in planning phase and it is funded by someone who believes in us.
We have strong validation by Schiff and the EuroPacific crew joining up with us at a SP higher than it is now.
We have a Pivotal Stroke trial that WILL HAPPEN but the market has not priced in because everyone is scared sh!tless.
Whether you believe we will ever get to the 5$ promised land is up to you.
If you think that we have nothing here and you should gather your pennies and leave, I think you are dead wrong.
We have many and broad patents that people maybe won't buy because we need them and won't sell them... but they are treading on intellectual property ground that is ours with their research and if they end up being successful.... they pay us to pitch their tent on our turf. Do you get my meaning? I am only speculating here but Alan Moore spoke quite long about the potential for licensing our assets at the special meeting in the Fall 2010. We are gradually but continually staking a claim to a large tract of IP territory so it is quite conceivable that other biotechs who are approaching (or encroaching) our IP may want/need to pay us to advance their products/techniques.
I thought the board could use a more upbeat shot in the arm on this beautiful Friday morning with the Stampede Parade rolling down the street.
The sky isn't falling people. It is low, yes, but it is on the way UP... not the way DOWN.
HnG